UNSPSC 51286101: Enoxamast

This classification denotes an anti-asthmatic agent with the molecular formula C13H10N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 08703R750L, chemically known as (4-(1,4-benzodioxan-6-yl)-2-thiazolyl)oxamic acid. but more generally known as enoxamast, which bears US NIH Compound Identifier 194595. European Medicines Agency schedules Enoxamast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06541MIG.

The term ENOXAMAST is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 39, No. 5, 1985, List 25). ENOXAMAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S1CC(NC1NC(=O)C(=O)O)C1CC2OCCOC2CC1.

UNSPSC 51286101 Enoxamast is a Commodity code covering pharmaceutical products procured by state and local health agencies. Based on recent state and local solicitations, the code encompasses emergency response medications and harm-reduction supplies — specifically antibiotic pharmaceuticals, opioid antagonists, and associated drug-disposal systems — purchased in bulk for public health programs, emergency preparedness stockpiles, and community health initiatives. State and local issuing bodies using this code include state departments of public health and county health departments, typically procuring through cooperative purchasing vehicles (such as MMCAP Infuse consortiums) or direct competitive bidding processes.

The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (IFB 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under a 12-month initial term with two renewal options. Seminole County, Florida issued an IFB (60459723LAS) posted June 30, 2026 with a July 26, 2023 response deadline for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly delivery to the Seminole County Community Health Building in Sanford. Recent activity centers in Illinois and Florida; procurement vehicles include both consortium piggyback arrangements and county-direct competitive bids, with contracts structured on fixed-fee pricing and initial two- to three-year terms.